MedPath

To evaluate the Safety and efficacy of Unani formulations in the treatment of Anorexia

Phase 2
Recruiting
Conditions
Anorexia, Zof al-IshtihÄ (Anorexia),
Registration Number
CTRI/2015/02/005591
Lead Sponsor
Central Council for Research in Unani MedicineCCRUM
Brief Summary

This study is designed as a multicentric open trial in patients with **Khafaqan (Palpitation)** After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically every week.  This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 04 weeks. . Laboratory parameters for safety assessment will be conducted at baseline, first follow up and on completion of the protocol therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
300
Inclusion Criteria

•Patients of either sex in the age group of 18-65 •Decreased Appetite with SNAQ ≤ 14.

Exclusion Criteria

•Patients having Anorexia nervosa •Patients with disorders requiring long term treatment •Known cases of Hepatic, Renal or Cardiac Ailments •History of addictions (Alcohol, Drugs) •Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in signs and symptoms2 weeks
Secondary Outcome Measures
NameTimeMethod
Hematological and biochemical assessments for safety2 weeks

Trial Locations

Locations (3)

Clinical Research Unit

🇮🇳

Meerut, UTTAR PRADESH, India

Clinical Research Unit, Kurnool

🇮🇳

Kurnool, ANDHRA PRADESH, India

Regional Research Institute of Unani Medicine, Bhadrak

🇮🇳

Bhadrak, ORISSA, India

Clinical Research Unit
🇮🇳Meerut, UTTAR PRADESH, India
DR MOHD TARIQ KHAN
Principal investigator
09012843253
doctormtk@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.